A recent study reveals that individuals who discontinue new slimming jabs like Mounjaro or Wegovy may regain reduced body mass much more quickly than those who halt traditional lifestyle regimens.
Research printed in a prominent medical journal shows that while overweight individuals can lose substantial amounts of their total mass while on the medication, the mass returns at an average rate of 0.8 kg per month after stopping.
"Individuals purchasing these medications must be cognizant of the danger of quick rebound weight gain when the therapy concludes," warns expert Dr. Susan Jebb.
That rate of recovery suggests a return to pre-treatment weight within about 18 months.
Analyzing Approaches
The study, which reviewed dozens of trials involving over 9,000 of patients, compared the results of GLP-1 agonists with other pills.
Scientists point out that individuals who lose weight through lifestyle changes alone generally experience a more gradual weight regain—approximately 100 grams monthly—post-intervention.
Explaining the Quick Rebound
Experts believe the mechanism of the jabs is key to understanding the accelerated regain.
The injections mimic a body's own chemical called glucagon-like peptide-1, which moderates hunger.
"Long-term administration of the hormone levels several times higher than normal may cause the body to generate a reduced amount of its own natural GLP-1, and could diminish responsiveness to its actions," noted Dr. Adam Collins, a nutrition researcher.
"Withdrawal of this medication leads to appetite is unsuppressed, making excessive eating much more probable."
A Lifelong Condition?
Health authorities advise the jabs for individuals with weight-linked health risks, accompanied by prescribed diet and exercise modifications.
A number of clinicians contend that, given the high risk of weight regain, the therapy is often long-term.
This perspective is reinforced by drug manufacturers, who state that the results "emphasize the chronic nature of excess weight," similar to managing conditions like hypertension.
User Testimonies
People who have come off the medication explain a intense resurgence of appetite.
"I experienced a trigger flipping and I was suddenly extremely hungry," described a patient.
This difficulty is worsened if patients have not established lasting lifestyle or habit changes during therapy.
Growing Use
Figures indicate that a significant number of people in the UK have used these injections in the past year, with interest being substantial.
- Use is greater among women than men.
- The middle-aged age group shows the greatest level of interest.
- A large proportion access the medications through private healthcare rather than the NHS.
Finally, clinicians emphasize that while these medications are effective tools for weight loss, they are not a magic solution and long-term success hinges on integrated lifestyle changes.
